Form 4: Inspire Medical Director Acquires Shares via Compensation

Inspire Medical Systems Director Gary Lee Ellis acquired 304 shares of common stock at $96.47 per share on January 15, 2026, as part of the company's non-employee director compensation policy.

Summary

• Gary Lee Ellis, a Director at Inspire Medical Systems, Inc. (INSP), acquired 304 shares of common stock.
• The transaction occurred on January 15, 2026, at a price of $96.47 per share.
• These shares were received in lieu of cash fees, consistent with the Company's Non-Employee Director Compensation Policy.
• Following this transaction, Mr. Ellis directly beneficially owns 6,758 shares of Inspire Medical Systems common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged purchase or sale plan.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even as part of a compensation plan, generally reflects continued alignment of interests and confidence in the company's long-term value. It's a positive signal, though not as strong as an open market purchase.

Positives

• A director increasing their stake, even through compensation, can signal confidence in the company's future prospects and alignment with shareholder interests.
• The transaction aligns with a pre-established compensation policy, indicating structured corporate governance and predictable insider equity movements.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

Insider transactions, such as director stock acquisitions, are routinely monitored by investors as they can provide insights into management's confidence in the company's prospects. While this specific transaction is part of a compensation policy rather than an open market purchase, it still represents an increase in insider ownership, which is generally viewed as a positive signal of alignment.

Corporate Governance

Related Party Transactions

• The acquisition of 304 shares of common stock by Director Gary Lee Ellis from Inspire Medical Systems, Inc. is a related party transaction, as it involves a company insider and is part of the director's compensation.

Stakeholder Impact

• Shareholders may view the director's increased equity stake as a positive sign of management's commitment and belief in the company's future performance.
• Employees are not directly impacted by this specific insider transaction, but a stable board and aligned director interests can contribute to overall company stability.

Key Dates

Recommendation

While the director's acquisition of shares is a positive signal, indicating alignment with shareholder interests and confidence in the company, it was part of a pre-established compensation policy rather than an open market purchase. This makes it an expected event rather than a strong new indicator for a 'buy' recommendation. Therefore, a 'hold' recommendation is appropriate, acknowledging the positive insider sentiment without suggesting a significant change in investment thesis based solely on this routine transaction.

Keywords

Inspire Medical Systems, INSP, Insider Transaction, Form 4, Director Stock Acquisition, Equity Compensation, Gary Lee Ellis, Rule 10b5-1